Register for a live broadcast to learn more about TRODELVY (sacituzumab govitecan-hziy) with Dr. Hope S. Rugo

ICYMI: 5 Most Recent FDA Approvals, June 23, 2020

Tuesday, June 23, 2020

As spring turns to summer, the FDA is not slowing down in approving drugs in the oncology space – some for very specific cancer types, and others (such as the recent approval of pembrolizumab) for a whole range of solid tumors that have a high mutational burden.

In case you missed it, here is a list of the 5 most recent FDA approvals:
Sign up for Oncology Nursing News emails and never miss an approval or the latest in the field of oncology nursing.

Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.
External Resources

MJH Associates
American Journal of Managed Care
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
OncNurse Resources

Continuing Education
Web Exclusives

About Us
Advisory Board
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.